Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Current Assets: 2021-2025

Historic Current Assets for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $130,152.

  • ProQR Therapeutics N.V's Current Assets rose 28.24% to $130,152 in Q3 2025 from the same period last year, while for Sep 2025 it was $130,152, marking a year-over-year increase of 28.24%. This contributed to the annual value of $164.4 million for FY2024, which is 25.62% up from last year.
  • Latest data reveals that ProQR Therapeutics N.V reported Current Assets of $130,152 as of Q3 2025, which was down 7.48% from $140,679 recorded in Q2 2025.
  • Over the past 5 years, ProQR Therapeutics N.V's Current Assets peaked at $219.1 million during Q4 2021, and registered a low of $87,894 during Q1 2021.
  • Moreover, its 3-year median value for Current Assets was $145,245 (2025), whereas its average is $51.1 million.
  • Per our database at Business Quant, ProQR Therapeutics N.V's Current Assets skyrocketed by 220,132.99% in 2022 and then tumbled by 99.93% in 2024.
  • Over the past 5 years, ProQR Therapeutics N.V's Current Assets (Quarterly) stood at $219.1 million in 2021, then fell by 28.06% to $157.6 million in 2022, then fell by 17.40% to $130.2 million in 2023, then slumped by 99.87% to $164,398 in 2024, then grew by 28.24% to $130,152 in 2025.
  • Its last three reported values are $130,152 in Q3 2025, $140,679 for Q2 2025, and $145,245 during Q1 2025.